共 50 条
- [31] Safety of Concurrent Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S343 - S343
- [32] Comparative Efficacy and Safety of Ozanimod vs Adalimumab and Vedolizumab in Patients with Moderately to Severely Active Ulcerative Colitis AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S314 - S314
- [33] Impact of Ozanimod (OZA) on Circulating Neutrophils: Results from the Phase 3 Japanese True North (J-TN) Study of Patients (Pts) With Moderately to Severely Active Ulcerative Colitis (UC) JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1350 - i1350
- [35] Efficacy and safety of tacrolimus in older adults with ulcerative colitis: a retrospective study BMC Gastroenterology, 24
- [36] Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study JOURNAL OF CROHNS & COLITIS, 2024, 18 (06): : 801 - 811
- [37] Association Between Fecal Calprotectin Cutoff Concentrations of 150 or 250 μg/g and Ozanimod Efficacy: A Post Hoc Analysis of the Phase 3 True North Study AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S775 - S776
- [39] Impact of Ozanimod on Interleukin-17A Levels and the Association With OZA Efficacy in Patients With Moderately to Severely Active Ulcerative Colitis: Data From the Phase 3 True North Study AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S867 - S867
- [40] Efficacy of ozanimod by patient response trajectory subgroups identified using group-based trajectory modelling: a post hoc analysis of the phase 3 True North study JOURNAL OF CROHNS & COLITIS, 2024, 18 : I216 - I217